AI Insight: Unitil's current price exceeds the fair value estimate by 17.1%, indicating potential overvaluation despite a high-confidence valuation. Divergent valuation methods range from negative to significantly higher values, reflecting uncertainty in cash flow projections. Financial health is fair with strong growth yet weak liquidity and leverage metrics, while downside risk appears negligible per Monte Carlo analysis.